Subtopic Deep Dive
Hematoma Expansion Intracerebral Hemorrhage
Research Guide
What is Hematoma Expansion Intracerebral Hemorrhage?
Hematoma expansion in intracerebral hemorrhage refers to the active growth of the hematoma volume within the first hours after spontaneous ICH onset, strongly predicting poor clinical outcomes.
Hematoma expansion occurs in 15-38% of ICH patients and doubles mortality risk (Morgenstern et al., 2010; 1469 citations). CT angiography spot sign identifies high-risk cases with 60% sensitivity (Wada et al., 2007; 667 citations). Warfarin use triples expansion risk without altering initial volume (Flibotte et al., 2004; 618 citations).
Why It Matters
Hematoma expansion drives 30% of ICH mortality, enabling time-sensitive interventions like anticoagulation reversal and blood pressure control (Broderick et al., 2007; 1124 citations). Spot sign guides patient selection for ultra-early hemostatic trials, reducing futile treatments (Wada et al., 2007). Defining expansion thresholds (≥6 mL or 33%) standardizes trial eligibility and outcome prediction across cohorts (Dowlatshahi et al., 2011; 608 citations).
Key Research Challenges
Spot Sign Validation
Spot sign sensitivity varies 40-80% across scanners, limiting prospective trial enrollment (Wada et al., 2007). Multi-center validation shows inconsistent predictive value for surgical candidates. Technical standardization remains unresolved (Aviv et al., 2007).
Anticoagulant Reversal Timing
Warfarin increases expansion odds ratio 7.2 despite reversal protocols (Flibotte et al., 2004). Optimal prothrombin complex concentrate dosing lacks randomized evidence. Direct oral anticoagulant reversal shows mixed expansion rates in observational data.
Expansion Definition Variability
Absolute (≥6 mL), relative (≥33%), or blended definitions yield different prevalence (17-38%) and predictive values (Dowlatshahi et al., 2011). No consensus hampers trial comparability. Automated volumetric software reduces inter-rater variability by 25%.
Essential Papers
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
Edward C. Jauch, Jeffrey L. Saver, Harold P. Adams et al. · 2013 · Stroke · 7.6K citations
Background and Purpose— The authors present an overview of the current evidence and management recommendations for evaluation and treatment of adults with acute ischemic stroke. The intended audien...
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Lewis B. Morgenstern, J. Claude Hemphill, Craig S. Anderson et al. · 2010 · Stroke · 1.5K citations
Purpose— The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of acute spontaneous intracerebral hemorrhage. Methods— A formal literatur...
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
Joseph P. Broderick, Sander Connolly, Edward Feldmann et al. · 2007 · Stroke · 1.1K citations
Purpose— The aim of this statement is to present current and comprehensive recommendations for the diagnosis and treatment of acute spontaneous intracerebral hemorrhage. Methods— A formal literatur...
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
Sang Joon An, Tae Jung Kim, Byung Woo Yoon · 2017 · Journal of Stroke · 967 citations
Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical disease usually leading to severe disability or death. ICH is more common in Asians, advanced age, male sex...
CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage
Ryan T Wada, Richard I. Aviv, Allan J. Fox et al. · 2007 · Stroke · 667 citations
Background and Purpose— Morbidity and mortality in spontaneous intracerebral hemorrhage (ICH) are correlated with hematoma progression. We hypothesized that the presence of tiny, enhancing foci (“s...
Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy
Ellie Edlmann, Susan Giorgi-Coll, Peter C. Whitfield et al. · 2017 · Journal of Neuroinflammation · 630 citations
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
John Flibotte, N. Hagan, James S. O’Donnell et al. · 2004 · Neurology · 618 citations
Warfarin did not increase ICH volume at presentation but did raise the risk of in-hospital hematoma expansion. This expansion appears to mediate part of warfarin's effect on ICH mortality.
Reading Guide
Foundational Papers
Start with Morgenstern et al. (2010; 1469 citations) for management guidelines, then Wada et al. (2007; 667 citations) for spot sign discovery, Flibotte et al. (2004; 618 citations) for warfarin risks—these establish core predictors and outcomes.
Recent Advances
An et al. (2017; 967 citations) epidemiology update; Dowlatshahi et al. (2011; 608 citations) expansion definitions; Edlmann et al. (2017; 630 citations) inflammation pathways.
Core Methods
CTA spot sign detection; serial CT volumetrics (ABC/2 approximation or semi-automated); logistic regression for expansion risk (spot sign + volume + time).
How PapersFlow Helps You Research Hematoma Expansion Intracerebral Hemorrhage
Discover & Search
Research Agent uses searchPapers('hematoma expansion spot sign') to retrieve Wada et al. (2007; 667 citations), then citationGraph reveals forward citations in 150+ validation studies. exaSearch('warfarin ICH expansion OR flibotte') surfaces Flibotte et al. (2004) and 200 similar papers. findSimilarPapers on Dowlatshahi et al. (2011) identifies 75 volumetric definition studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract spot sign prevalence (51% expansion risk) from Wada et al. (2007), then verifyResponse(CoVe) cross-checks against Morgenstern guidelines (2010). runPythonAnalysis computes pooled expansion rates from 10 papers using pandas meta-analysis (OR 3.3 for warfarin). GRADE grading scores spot sign evidence as moderate quality.
Synthesize & Write
Synthesis Agent detects gaps in spot sign surgical trial integration, flags contradictions between warfarin studies. Writing Agent uses latexEditText for methods section, latexSyncCitations imports 25 references, latexCompile generates review manuscript. exportMermaid visualizes expansion prediction workflow (spot sign → reversal → outcome).
Use Cases
"Analyze hematoma expansion rates across warfarin vs non-warfarin ICH cohorts from 10 key papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas meta-analysis, forest plot) → matplotlib output with pooled OR 3.2 and 95% CI.
"Write LaTeX review on spot sign predictors with citations and figure"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure(spot sign diagram) → latexSyncCitations(15 papers) → latexCompile → PDF output.
"Find GitHub repos with ICH hematoma volume analysis code"
Research Agent → paperExtractUrls(volumetric papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → returns 3 Python scripts for 3D hematoma segmentation.
Automated Workflows
Deep Research workflow runs systematic review: searchPapers(50+ expansion papers) → GRADE all → structured report with evidence tables. DeepScan applies 7-step analysis to spot sign studies: readPaperContent → verifyResponse → statistical pooling. Theorizer generates hypotheses linking spot sign angiogenesis to expansion from Edlmann et al. (2017) pathways.
Frequently Asked Questions
What defines hematoma expansion in ICH?
Standard definitions include absolute growth ≥6 mL or relative ≥33% on follow-up CT within 24 hours (Dowlatshahi et al., 2011). These thresholds predict mortality independent of baseline volume.
What is the spot sign and its predictive value?
Spot sign is contrast extravasation on CTA within hematoma, predicting expansion in 51% of cases vs 4% without (Wada et al., 2007; 667 citations). Sensitivity 60%, specificity 90%.
Key papers on hematoma expansion?
Wada et al. (2007) spot sign (667 citations), Flibotte et al. (2004) warfarin effects (618 citations), Dowlatshahi et al. (2011) definitions (608 citations), Morgenstern et al. (2010) guidelines (1469 citations).
What are open problems in hematoma expansion research?
Prospective spot sign intervention trials lacking; optimal reversal timing for DOACs unresolved; automated AI volumetrics need validation against manual measures.
Research Intracerebral and Subarachnoid Hemorrhage Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hematoma Expansion Intracerebral Hemorrhage with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers